SHEN26 is an investigational new drug which is being evaluated by Shenzhen Kexing Pharmaceuticals for the treatment of COVID-19. It is an RNA replicase inhibitor.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.